Cefotaxime/sulbactam plus gentamicin as a potential carbapenem- and amikacin-sparing first-line combination for neonatal sepsis in high ESBL prevalence settings

BACKGROUND: Infection with ESBL-producing Enterobacteriaceae infection is ubiquitous in some neonatal ICUs and increasing levels of antibiotic resistance are a cause for urgent concern. Delineation of bacterial and viral sepsis can be challenging, often leading to patients receiving empirical antibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Readman, J B, Acman, M, Hamawandi, A, Chiu, Cheng-Hsun, Sharland, M, Lindsay, J A, Standing, J F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393883/
https://www.ncbi.nlm.nih.gov/pubmed/37283195
http://dx.doi.org/10.1093/jac/dkad177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393883/
https://www.ncbi.nlm.nih.gov/pubmed/37283195
http://dx.doi.org/10.1093/jac/dkad177

Ejemplares similares